How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth

In late April 2026, Boston Scientific reported quarterly revenue of US$5.20 billion, up 11.6% year on year and ahead of ...

Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition

Boston Scientific (BSX) stock has been under pressure after management flagged slowing growth in its Watchman heart implant business, a key contributor to earnings. The company reaffirmed full year ...

Boston Scientific hits 52-week low on Watchman headwinds

Shares of Boston Scientific (BSX) lost ~10% in the morning hours on Wednesday to hit a 52-week low after the MedTech ...

Boston Scientific hits two-year low after flagging weaker demand for heart device

By Kamal Choudhury May 27 (Reuters) - Boston Scientific shares sank to their lowest in over two years on Wednesday, after the medical device maker warned it was facing pressure due to softer uptake of ...
AOL

What to Know About Medicare Coverage for Watchman Surgery

Medicare typically covers Watchman surgery under Part A (hospital insurance) if deemed medically necessary for reducing stroke risk in patients with non-valvular atrial fibrillation. Coverage often ...